Skip to main content

 

Main menu

  • Home
  • Articles
    • Current Issue
    • Archive
    • Most Read
    • On The Horizon Collection
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Services
    • Email Alerts
    • RSS Feeds
  • More
    • AAI Disclaimer
    • Feedback
  • Other Publications
    • American Association of Immunologists
    • The Journal of Immunology

User menu

  • Log in

Search

  • Advanced search
ImmunoHorizons
  • Other Publications
    • American Association of Immunologists
    • The Journal of Immunology
  • Log in
ImmunoHorizons

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Archive
    • Most Read
    • On The Horizon Collection
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Services
    • Email Alerts
    • RSS Feeds
  • More
    • AAI Disclaimer
    • Feedback
  • Follow ImmunoHorizons on Twitter
  • Follow ImmunoHorizons on RSS
Open Access

Efficacy of the Combination of Metformin and CTLA4Ig in the (NZB × NZW)F1 Mouse Model of Lupus Nephritis

Caleb Cornaby, Ahmed S. Elshikha, Xiangyu Teng, Seung-Chul Choi, Yogesh Scindia, Anne Davidson and Laurence Morel
ImmunoHorizons June 1, 2020, 4 (6) 319-331; DOI: https://doi.org/10.4049/immunohorizons.2000033
Caleb Cornaby
*Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Caleb Cornaby
Ahmed S. Elshikha
*Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610;
†Department of Pharmaceutics, Zagazig University, Zagazig, Sharkia 44519, Egypt;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ahmed S. Elshikha
Xiangyu Teng
*Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seung-Chul Choi
*Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Seung-Chul Choi
Yogesh Scindia
‡Department of Medicine, University of Florida, Gainesville, FL 32610; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yogesh Scindia
Anne Davidson
§Feinstein Institutes for Medical Research, Manhasset, NY 11030
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurence Morel
*Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF
Loading

Article Information

vol. 4 no. 6 319-331
DOI 
https://doi.org/10.4049/immunohorizons.2000033
PubMed 
32540987

Published By 
The American Association of Immunologists, Inc.
Online ISSN 
2573-7732
History 
  • Received May 7, 2020
  • Accepted May 27, 2020
  • Published online June 15, 2020.

Copyright & Usage 
Copyright © 2020 The Authors This article is distributed under the terms of the CC BY-NC 4.0 Unported license.

Author Information

  1. Caleb Cornaby*,1,2,
  2. Ahmed S. Elshikha*,†,2,
  3. Xiangyu Teng*,
  4. Seung-Chul Choi*,
  5. Yogesh Scindia‡,
  6. Anne Davidson§ and
  7. Laurence Morel*
  1. *Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL 32610;
  2. †Department of Pharmaceutics, Zagazig University, Zagazig, Sharkia 44519, Egypt;
  3. ‡Department of Medicine, University of Florida, Gainesville, FL 32610; and
  4. §Feinstein Institutes for Medical Research, Manhasset, NY 11030
  1. Address correspondence and reprint requests to:
    Dr. Laurence Morel, University of Florida, Box 100275, Gainesville, FL 32610-0275. E-mail address: morel{at}ufl.edu
  1. ↵2 C.C. and A.S.E. contributed equally to this work.

  • ↵1 Current address: McLendon Clinical Laboratories, University of North Carolina at Chapel Hill Hospitals, Chapel Hill, NC.

View Full Text

Article usage

Article usage: June 2020 to December 2020

AbstractFullPdf
Jun 20202114282
Jul 202038639
Aug 2020421256
Sep 202039933
Oct 202039320
Nov 2020011621
Dec 2020110833
Total 202035856284
Total35856284

PreviousNext
Back to top

In this issue

ImmunoHorizons: 4 (6)
ImmunoHorizons
Vol. 4, Issue 6
1 Jun 2020
  • Table of Contents
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about ImmunoHorizons.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy of the Combination of Metformin and CTLA4Ig in the (NZB × NZW)F1 Mouse Model of Lupus Nephritis
(Your Name) has forwarded a page to you from ImmunoHorizons
(Your Name) thought you would like to see this page from the ImmunoHorizons web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Efficacy of the Combination of Metformin and CTLA4Ig in the (NZB × NZW)F1 Mouse Model of Lupus Nephritis
Caleb Cornaby, Ahmed S. Elshikha, Xiangyu Teng, Seung-Chul Choi, Yogesh Scindia, Anne Davidson, Laurence Morel
ImmunoHorizons June 1, 2020, 4 (6) 319-331; DOI: 10.4049/immunohorizons.2000033

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Efficacy of the Combination of Metformin and CTLA4Ig in the (NZB × NZW)F1 Mouse Model of Lupus Nephritis
Caleb Cornaby, Ahmed S. Elshikha, Xiangyu Teng, Seung-Chul Choi, Yogesh Scindia, Anne Davidson, Laurence Morel
ImmunoHorizons June 1, 2020, 4 (6) 319-331; DOI: 10.4049/immunohorizons.2000033
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Regulatory T Cell–Derived TRAIL Is Not Required for Peripheral Tolerance
  • Barrier Housing and Gender Effects on Allergic Airway Disease in a Murine House Dust Mite Model
  • Enhanced Immunotherapeutic Efficacy of Anti–PD-L1 Antibody in Combination with an EP4 Antagonist
Show more CLINICAL AND TRANSLATIONAL IMMUNOLOGY

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Privacy Policy
  • Disclaimer
  • Contact us

Journal Services

  • Email Alerts
  • RSS Feeds

Copyright© 2021 by The American Association of Immunologists, Inc

Online ISSN 2573-7732